Cart
sales@molnova.com
Totrombopag
CAS No. 376592-42-6
Totrombopag( —— )
Catalog No. M34722 CAS No. 376592-42-6
Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 787 | In Stock |
|
| 10MG | 1074 | In Stock |
|
| 25MG | 1511 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | 2325 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 4557 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTotrombopag
-
NoteResearch use only, not for human use.
-
Brief DescriptionTotrombopag (SB559448) is a candidate compound for action on RSV polymerase.
-
DescriptionTotrombopag (SB559448) is a candidate compound for action on RSV polymerase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorRSV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number376592-42-6
-
Formula Weight466.49
-
Molecular FormulaC25H22N8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(N=C(C)C1N=NC2=C(O)C(=CC=C2)C3=CC(=CC=C3)C=4NN=NN4)C5=CC(C)=C(C)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AS2863619
AS2863619 is an orally active?inhibitor of cyclin-dependent kinase 8 (CDK8) and CDK19 (IC50s of 0.61 nM and 4.28 nM, respectively).
-
NSC 370284
NSC 370284 is a small molecule that directly binds to and inhibits STAT3/5, significantly and selectively suppresses the viability of AML cells with high level of TET1 expression both in vitro and in vivo.
-
NT219
NT219 is a dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3, enhances the aggregation of misfolded prion protein NT219 affects the levels of certain molecular chaperones and inhibits STAT3 phosphorylation NT219 is useful for the study of cancer and neurodegenerative diseases.
